Skip to search formSkip to main contentSkip to account menu

CD22 Expressing Cell Count

Known as: B-Cell Receptor CD22 Expressing Cell Count, CD22 
The determination of the amount of CD22 expressing cells per unit present in a sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
CD22 is a B‐lineage differentiation antigen that has emerged as a leading therapeutic target in acute lymphoblastic leukemia (ALL… 
2015
2015
OBJECTIVE This study was to investigate the cell morphology and cell immune phenotypic characteristics in patients with multiple… 
Highly Cited
2013
Highly Cited
2013
Epratuzumab, a humanized anti-CD22 antibody, is currently in clinical trials of B-cell lymphomas and autoimmune diseases… 
2013
2013
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background. Epratuzumab, a humanized anti-CD22… 
2012
2012
Abstract 1357 Background. The humanized anti-CD22 antibody, epratuzumab, has demonstrated therapeutic activity in clinical trials… 
2009
2009
B cells from systemic lupus erythematosus (SLE) patients display signalling defects that may underlie disease pathogenesis… 
2006
2006
BACKGROUND Contemporary risk adapted treatment protocols for childhood acute lymphoblastic leukemia (ALL) rely on accurate risk… 
Highly Cited
1997
1991
1991
The monoclonal antibodies (MoAbs) CD22 and CD11c recognize B-lymphocyte- and monocyte-associated antigens, respectively. Reports…